118 related articles for article (PubMed ID: 36595922)
1. Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens.
Weskamm LM; Dahlke C; Addo MM
STAR Protoc; 2022 Dec; 3(4):101902. PubMed ID: 36595922
[TBL] [Abstract][Full Text] [Related]
2. The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
Fiorino F; Ciabattini A; Sicuranza A; Pastore G; Santoni A; Simoncelli M; Polvere J; Galimberti S; Baratè C; Sammartano V; Montagnani F; Bocchia M; Medaglini D
Front Immunol; 2022; 13():1017863. PubMed ID: 36248803
[TBL] [Abstract][Full Text] [Related]
3. Protocol to quantify and phenotype SARS-CoV-2-specific T cell response using a rapid flow-cytometry-based whole blood assay.
Mutavhatsindi H; Riou C
STAR Protoc; 2022 Dec; 3(4):101771. PubMed ID: 36272131
[TBL] [Abstract][Full Text] [Related]
4. A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19.
Martin S; Jégou G; Nicolas A; Le Gallo M; Chevet É; Godey F; Avril T
STAR Protoc; 2022 Mar; 3(1):101229. PubMed ID: 35287269
[TBL] [Abstract][Full Text] [Related]
5. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
Quinti I; Locatelli F; Carsetti R
Front Immunol; 2021; 12():815404. PubMed ID: 35126372
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
7. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
Vesper N; Ortiz Y; Bartels-Burgahn F; Yang J; de la Rosa K; Tenbusch M; Schulz S; Finzel S; Jäck HM; Eibel H; Voll RE; Reth M
Front Immunol; 2021; 12():730766. PubMed ID: 34630410
[TBL] [Abstract][Full Text] [Related]
8. B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain.
Rouers A; Tay MZ; Ng LFP; Renia L
STAR Protoc; 2023 Mar; 4(1):102130. PubMed ID: 36853725
[TBL] [Abstract][Full Text] [Related]
9. Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue.
Mahallawi WH; Aljeraisi TM
Clin Immunol; 2021 Oct; 231():108850. PubMed ID: 34506944
[TBL] [Abstract][Full Text] [Related]
10. A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients.
Goh YS; Ng LFP; Renia L
STAR Protoc; 2021 Sep; 2(3):100671. PubMed ID: 34179835
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling.
Li Y; Lai DY; Tao SC
STAR Protoc; 2021 Sep; 2(3):100707. PubMed ID: 34308376
[TBL] [Abstract][Full Text] [Related]
12. Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant.
Sokal A; Broketa M; Barba-Spaeth G; Meola A; Fernández I; Fourati S; Azzaoui I; de La Selle A; Vandenberghe A; Roeser A; Bouvier-Alias M; Crickx E; Languille L; Michel M; Godeau B; Gallien S; Melica G; Nguyen Y; Zarrouk V; Canoui-Poitrine F; Noizat-Pirenne F; Megret J; Pawlotsky JM; Fillatreau S; Simon-Lorière E; Weill JC; Reynaud CA; Rey FA; Bruhns P; Chappert P; Mahévas M
Immunity; 2022 Jun; 55(6):1096-1104.e4. PubMed ID: 35483354
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination.
Moore T; Hossain R; Doores KJ; Shankar-Hari M; Fear DJ
Viral Immunol; 2022 Jul; 35(6):425-436. PubMed ID: 35857310
[TBL] [Abstract][Full Text] [Related]
14. Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
Pušnik J; König J; Mai K; Richter E; Zorn J; Proksch H; Schulte B; Alter G; Streeck H
J Virol; 2022 Aug; 96(15):e0076022. PubMed ID: 35862718
[TBL] [Abstract][Full Text] [Related]
15. mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants.
Sokal A; Barba-Spaeth G; Fernández I; Broketa M; Azzaoui I; de La Selle A; Vandenberghe A; Fourati S; Roeser A; Meola A; Bouvier-Alias M; Crickx E; Languille L; Michel M; Godeau B; Gallien S; Melica G; Nguyen Y; Zarrouk V; Canoui-Poitrine F; Pirenne F; Mégret J; Pawlotsky JM; Fillatreau S; Bruhns P; Rey FA; Weill JC; Reynaud CA; Chappert P; Mahévas M
Immunity; 2021 Dec; 54(12):2893-2907.e5. PubMed ID: 34614412
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.
Taborska P; Lastovicka J; Stakheev D; Strizova Z; Bartunkova J; Smrz D
Immun Inflamm Dis; 2021 Dec; 9(4):1452-1467. PubMed ID: 34314576
[TBL] [Abstract][Full Text] [Related]
17. Transient transfection and purification of SARS-CoV-2 spike protein from mammalian cells.
Stalls V; Janowska K; Acharya P
STAR Protoc; 2022 Sep; 3(3):101603. PubMed ID: 35983170
[TBL] [Abstract][Full Text] [Related]
18. High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines.
Pape KA; Dileepan T; Kabage AJ; Kozysa D; Batres R; Evert C; Matson M; Lopez S; Krueger PD; Graiziger C; Vaughn BP; Shmidt E; Rhein J; Schacker TW; Khoruts A; Jenkins MK
Cell Rep; 2021 Oct; 37(2):109823. PubMed ID: 34610291
[TBL] [Abstract][Full Text] [Related]
19. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay.
Nasser H; Shimizu R; Ito J; ; Saito A; Sato K; Ikeda T
STAR Protoc; 2022 Dec; 3(4):101773. PubMed ID: 36313538
[TBL] [Abstract][Full Text] [Related]
20. Durable SARS-CoV-2 B cell immunity after mild or severe disease.
Ogega CO; Skinner NE; Blair PW; Park HS; Littlefield K; Ganesan A; Dhakal S; Ladiwala P; Antar AA; Ray SC; Betenbaugh MJ; Pekosz A; Klein SL; Manabe YC; Cox AL; Bailey JR
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33571162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
